X4 Pharmaceuticals Announces Pricing Of $135 Million Underwritten Public Offering At $2.90 Per Share
ReutersOct 24, 2025 4:39 AM
Oct 24 (Reuters) - X4 Pharmaceuticals Inc XFOR.O:
X4 PHARMACEUTICALS ANNOUNCES PRICING OF $135 MILLION UNDERWRITTEN PUBLIC OFFERING
X4 PHARMACEUTICALS INC - PRICES PUBLIC OFFERING AT $2.90 PER SHARE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Thinking of investing in SOL? Here's a deep dive into Solana’s price trends and future outlook
Solana has demonstrated strong technical resilience and ecosystem growth in 2025. If it continues expanding use cases, stabilizing network performance, and navigating regulatory hurdles, SOL could become a core Web3 infrastructure asset. Institutions remain bullish on its long-term potential, especiTradingKey
2 hours ago
Intel Q3 Earnings Preview: Surge in Partnerships and Investments — Should You Bet Against a Turnaround?
TradingKey - Semiconductor chip manufacturer Intel (INTC) will report its Q3 2025 earnings after market close on Thursday, October 23, with investors watching closely to see if the company can finally prove it’s on a credible path to profitability. This quarter could mark a turning point, driven byTradingKey
20 hours ago
Tesla Q3 Earnings Report: How Far Is the Stock Price from Cathie Wood's $4000 Target?
TradingKey - In Q3 2025, Tesla reported revenue of $28.1 billion, a 12% year-over-year increase, surpassing Wall Street expectations and setting a new company record.TradingKey
20 hours ago
Can Zcash (ZEC) Sustain Its Rally? What’s Next for Its Price Trajectory?
Launched in 2016, Zcash (ZEC) is a cryptocurrency focused on privacy protection. Its key innovation lies in selective privacy, allowing users to choose between transparent and shielded transactions.TradingKey
Sat, Oct 18
Broadcom Q3 FY2025 Earnings Review: AI Surge and VMware Synergy Fuel Record Performance
TradingKey - Broadcom Inc. (NASDAQ: AVGO) delivered a strong fiscal Q3 2025, with results driven by AI networking strength and continued VMware integration. Revenue and EPS both topped expectations, reinforcing the company’s role as an essential player in the AI infrastructure buildout.TradingKey
Fri, Sep 5
